Contributor Disclosures for Gallbladder Tumors
Role Name Disclosure Details
Author Michael K McLeod, MD, FACE, FACS, Associate Professor of Surgery, College of Human Medicine, Program Director of Surgery and Assistant Chairman of the Department of Surgery, Kalamazoo Center for Medical Studies, Michigan State University Nothing to discloseDetails
Coauthor Tara Mancl, MD, Staff Physician, Department of Surgery, Michigan State University, Kalamazoo Center for Medical Studies Nothing to discloseDetails
Coauthor Michel M Murr, MD, Associate Professor, Department of Surgery, Director, Department of Bariatric Surgery, University of South Florida Nothing to discloseDetails
Medical Editor Alex Jacocks, MD, Program Director, Professor, Department of Surgery, University of Oklahoma School of Medicine Nothing to discloseDetails
Pharmacy Editor Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine Nothing to discloseDetails
Managing Editor Michael A Grosso, MD, Department of Cardiothoracic Surgery, St Francis Hospital Nothing to discloseDetails
CME Editor Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy Nothing to discloseDetails
Chief Editor John Geibel, MD, DSc, MA, Professor, Department of Surgery, Section of Gastrointestinal Medicine, and Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director of Surgical Research, Department of Surgery, Yale-New Haven Hospital AMGEN
AMGEN
Details









Contributor:
Contributor Disclosure:
Michael K McLeod, Author  The contributor discloses no conflict of interest. 









Contributor Disclosure


Contributor:
Contributor Disclosure:
Tara Mancl, Coauthor  The contributor discloses no conflict of interest. 









Contributor Disclosure


Contributor:
Contributor Disclosure:
Michel M Murr, Coauthor  The contributor discloses no conflict of interest. 









Contributor Disclosure


Contributor:
Contributor Disclosure:
Alex Jacocks, Medical Editor  The contributor discloses no conflict of interest. 






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
Francisco Talavera

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Off label or investigational use of medication









Contributor Disclosure


Contributor:
Contributor Disclosure:
Michael A Grosso, Managing Editor  The contributor discloses no conflict of interest. 









Contributor Disclosure


Contributor:
Contributor Disclosure:
Paolo Zamboni, CME Editor  The contributor discloses no conflict of interest. 






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
John Geibel

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

AMGEN
RoyaltyOther 
AMGEN
Consulting feeConsulting 
Off label or investigational use of medication